Diagnostic Medical Systems

Equities

ALDMS

FR0012202497

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 09:09:58 2024-04-30 EDT			5-day change	1st Jan Change
1.035 ^EUR	+1.97%		0.00%	-8.81%

04-18	Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-09	Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29%	MT

Diagnostic Medical Systems S.A. cancelled the acquisition of Stemcis SAS.

August 02, 2016

Diagnostic Medical Systems S.A. (ENXTPA:DGM) agreed to acquire Stemcis SAS for €2.5 million in stock on August 3, 2015. As a consideration, Diagnostic Medical Systems will issue 9.17 million new shares. Atout Capital acted as a financial advisor to Diagnostic Medical Systems. Diagnostic Medical Systems S.A. (ENXTPA:DGM) cancelled the acquisition of Stemcis SAS on August 3, 2016.

Latest news about Diagnostic Medical Systems

Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-17	CI
Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29%	02-09	MT
Lantheus Sued by Novartis Entities for Patent Infringement	01-26	DJ
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests	23-10-11	MT
Diagnostic Medical Systems S.A. completed the acquisition of Solutions For Tomorrow AB from Verso Capital Oy and Other Shareholder.	23-10-02	CI
Diagnostic Medical Systems S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-21	CI
Diagnostic Medical Systems S.A. signed an agreement to acquire Solutions For Tomorrow AB from Verso Capital Oy for SEK 44.8 million.	23-07-25	CI
Shineco Unit's Cardiac Test Receives Regulatory Approval in China	23-07-10	MT
Global markets live: Stellantis, Diageo, Boeing, Shell, Barclays...	23-06-07
DMS : Euroland initiates buy coverage	23-05-31	CF
Eurobio Scientific Secures IVDR CE Marking for Diagnostic Tests	23-05-24	MT
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Sector Update: Health Care Stocks' Recovery Stall Short of Positive Ground	23-01-27	MT
Sector Update: Health Care Stocks Sinking as Investor Attention Looks to Other Sectors	23-01-27	MT
Sector Update: Health Care	23-01-27	MT
Diagnostic Medical Systems Unit Receives Order for Radiology Tables in Italy	23-01-12	MT
PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4%	22-12-21	MT
An unknown buyer signed a memorandum of understanding to acquire 43.41% stakes of Hybrigenics SA from Diagnostic Medical Systems S.A..	22-10-20	CI
Diagnostic Medical Systems S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-30	CI
MedMira Provides Update on New In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market	22-05-27	MT
Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
Lantheus Holdings Posts Higher Q4 Adjusted Earnings, Revenue; Shares Rise Pre-Bell	22-02-24	MT
Diagnostic Medical Systems Takes Majority Stake In Asit Biotech	22-01-25	MT
CES Management SA agreed to acquire DMS Wellness division of Diagnostic Medical Systems from Diagnostic Medical Systems S.A..	22-01-12	CI

Chart Diagnostic Medical Systems

Duration

Period

More charts

Company Profile

Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (62.6%), North and South America (17.7%), Asia (6.8%), Middle East (4.5%), Africa (3.8%), Oceania (1.1%) and other (3.5%).

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Imaging Systems

	1st Jan change	Capi.
DIAGNOSTIC MEDICAL SYSTEMS	-8.81%	19.16M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.25%	15.01B
IRAY TECHNOLOGY COMPANY LIMITED	-38.91%	2.91B
SONOSCAPE MEDICAL CORP.	-12.68%	2.46B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-12.18%	1.46B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+41.29%	519M
GUERBET	+92.56%	499M
DETECTION TECHNOLOGY OYJ	+14.23%	243M
VIEWORKS CO., LTD.	+2.04%	183M

Medical Imaging Systems